NPI: 1003862426 · CHARLOTTE, NC 28227 · Family Medicine Physician · NPI assigned 05/26/2006
Authorized official WALTON, LEEA controls 20+ related entities in our dataset. Read more
| Authorized Official | WALTON, LEEA (RCS MANAGER) |
| NPI Enumeration Date | 05/26/2006 |
Other providers sharing the same authorized official: WALTON, LEEA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 3,121 | $117K |
| 2019 | 3,488 | $176K |
| 2020 | 2,902 | $148K |
| 2021 | 14,201 | $247K |
| 2022 | 30,541 | $277K |
| 2023 | 34,219 | $233K |
| 2024 | 45,715 | $127K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5,010 | 4,194 | $407K |
| 99199 | Unlisted special service, procedure or report | 116,478 | 113,917 | $392K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5,601 | 4,855 | $328K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1,449 | 1,332 | $61K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 498 | 476 | $43K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 270 | 256 | $29K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 920 | 872 | $17K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 220 | 178 | $10K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 360 | 347 | $10K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 62 | 50 | $6K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 38 | 25 | $5K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 458 | 446 | $4K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 52 | 42 | $3K |
| 99215 | Prolong outpt/office vis | 25 | 17 | $3K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 158 | 125 | $3K |
| 90686 | 553 | 525 | $2K | |
| 90474 | 57 | 57 | $1K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 14 | 13 | $569.89 |
| 90461 | 348 | 317 | $243.48 | |
| 92551 | 541 | 467 | $85.84 | |
| 99173 | 590 | 498 | $62.52 | |
| 90698 | 100 | 100 | $0.00 | |
| 90744 | 41 | 38 | $0.00 | |
| 90680 | 57 | 57 | $0.00 | |
| G8732 | No documentation of pain assessment, reason not given | 13 | 13 | $0.00 |
| 90670 | 248 | 246 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 13 | 13 | $0.00 |
| G8541 | Functional outcome assessment using a standardized tool not documented, reason not given | 13 | 13 | $0.00 |